Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01556828 · ClinicalTrials.gov registry record
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 70
- Enrollment target
NCT01556828: Clinical Trial study, sponsored by Stanford University.
NCT01556828 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01556828 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01556828
The ClinicalTrials.gov registry entry for NCT01556828 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01556828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01556828 about?
NCT01556828 is a clinical study titled "Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing". The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated ...
What is the current status of trial NCT01556828?
This trial is currently terminated. The enrollment target is 70 participants. The study started on 2011-06. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01556828?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.